We are live on ! Find out more
BCI

Bain Capital Investors Portfolio holdings

AUM $4.82B
1-Year Est. Return 35.43%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+35.43%
3 Year Est. Return
+91.12%
5 Year Est. Return
+78.55%
10 Year Est. Return
+1,013.83%
AUM
$3.14B
AUM Growth
-$748M
Cap. Flow
-$546M
Cap. Flow %
-17.41%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NTNX icon
Nutanix
NTNX
+$404M
2
WAY
Waystar Holding Corp
WAY
+$143M

Sector Composition

Rank Sector Weight
1 Healthcare 86.83%
2 Technology 13.05%
3 Communication Services 0.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGRY icon
1
Surgery Partners
SGRY
$1.89B
$1.11B 35.4%
49,946,972
– –
WAY
2
Waystar Holding Corp
WAY
$4.74B
$738M 23.53%
18,055,049
-3,699,487
-17% -$143M
KMTS
3
Kestra Medical Technologies
KMTS
$1.62B
$448M 14.28%
27,019,225
– –
AVAH icon
4
Aveanna Healthcare
AVAH
$2.71B
$427M 13.61%
81,600,880
– –
NTNX icon
5
Nutanix
NTNX
$18.4B
$409M 13.05%
5,355,285
-5,605,650
-51% -$404M
ADV icon
6
Advantage Solutions
ADV
$425M
$3.81M 0.12%
115,600
– –

Similar funds

Bain Capital Investors's Q2 2025 Portfolio in Review

As of Q2 2025, Bain Capital Investors held 6 positions worth $3.14B, down 19% from $3.88B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bain Capital Investors withdrew a net $546M in Q2 2025, reducing 2 holdings. Its largest reduction was Nutanix, cutting an estimated $404M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 80% a quarter earlier, followed by Technology and Communication Services.

  • Bain Capital Investors's biggest Q2 2025 reduction was Nutanix, cutting an estimated $404M.
  • Bain Capital Investors's ten largest holdings make up 100% of its $3.14B portfolio in Q2 2025.
  • Bain Capital Investors opened 0 new positions and closed 0 in Q2 2025.
  • Bain Capital Investors's portfolio value fell 19% quarter-over-quarter to $3.14B.

Based on Bain Capital Investors's 13F filing for Q2 2025, filed 14 Aug 2025.